David C Tully
4PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.Vincent H J Leonard, Dianna B Vidales, Benjamin R Taft
|Jul 23, 2025
Discovery and Optimization of a Novel Series of Influenza A Virus Replication Inhibitors Targeting the Nucleoprotein Protein-Protein Interaction.Benjamin R Taft, Matthew J Hesse, Mulugeta Mamo
|Jan 16, 2020
Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis.Donatella Chianelli, Paul V Rucker, Jason Roland
|Nov 18, 2017
Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).David C Tully, Paul V Rucker, Donatella Chianelli
Pageof 1
